Helicobacter pylori Eradication and Gastric Preneoplastic Conditions: A Randomized, Double-Blind, Placebo-Controlled Trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 1, 2004, Pages 4-10

  Ley, Catherine ^a   Mohar, Alejandro ^c,d   Guarner, Jeannette ^e   Herrera Goepfert, Roberto ^c   Figueroa, Luz Sanchez ^a,f   Halperin, David ^f   Johnstone, Iain ^a   Parsonnet, Julie ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f DEPARTAMENTO DE CONSERVACIÓN DE LA BIODIVERSIDAD   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE;

ADULT; ARTICLE; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DYSGEUSIA; ENDOSCOPY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ADENOCARCINOMA; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CANCER;

ADENOCARCINOMA; ADULT; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; RISK FACTORS; STOMACH NEOPLASMS;

EID: 1642487258     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-03-0124     Document Type: Article

References (32)

1. Murray, C. J., and Lopez, A. D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet, 349: 1269-1276, 1997.
2. Correa, P., Cuello, C., Duque, E., Burbano, L. C., Garcia, F. T., Bolanos, O., et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. J. Natl. Cancer Inst. 57: 1027-1035, 1976.
3. Correa, P., Haenszel, W., Cuello, C., Zavala. D. E., Fontham, E., Zarama, G., et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res., 50: 4737-4740, 1990.
4. IARC Working Group on the Evaluation ol Carcinogenic Risks to Humans. Helicobacter pylori. Schistosomes, liver flukes and Helicobacter pylori: views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, pp. 177-240. Lyon, France: IARC. 1994.
5. Potter, J. D., and Steinmetz, K. Vegetables, fruit and phytoestrogens as preventive agents. IARC Sci. Publ., 139: 61-90, 1996.
6. Forman, D. Lessons from ongoing intervention studies, In: R. H. Hunt and G. N. Tytgat (eds.), Helicobacter pylori: Basic Mechanisms to Clinical Cure, 1998. pp. 354-361. Dordrecht: Kluwer Academic Publishers. 1998.
7. Parsonnet, J., Harris, R. A., Hack, H. M., and Owens, D. K. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet, 348: 150-154, 1996.
8. Kelloff, G. J., Siginan, C. C., Johnson, K. M., Boone, C. W., Greenwald, P., Crowell, J. A., et al. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer. Cancer Epidemiol. Biomark. Prev., 9: 127-137, 2000.
9. Munoz, N., Vivas, J., Buiatti. E., Kato, I., and Oliver, W. Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data. IARC Sci. Publ., 139: 125-133, 1996.
10. Correa. P., Fontham, E. T., Bravo. J. C., Bravo, L. E., Ruiz, B., Zaraina, G., et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J. Natl. Cancer Inst. (Bethesda), 92: 1881-1888, 2000.
11. Sung, J. J., Lin, S. R., Ching, J. Y., Zhou, L. Y., To, K. F., Wang, R. T., et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology, 119: 7-14, 2000.
12. Halperin, D. C., Belgrade, M. E., and Mohar, A. Stomach cancer cluster in Mexico. Lancet, 2: 1055, 1988.
13. Ley, C., Mohar, A., Guamer, J., Herrera-Goepfert, R., Figueroa, L. S., Halperin, D., et al. Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol. Biomark. Prev., 10: 107-112, 2001.
14. Parsonnet, J., Friedman, G. D., Orentreich, N., and Vogelman, J. H. Risk for gastric cancer in persons with CagA positive and CagA negative Helicobacter pylori infection. Gut, 40: 297-301, 1997.
15. Efron, B. Forcing a sequential experiment to be balanced. Biometrika, 58: 403-417, 1971.
16. Dixon, M. F., Genta, R. M., Yardley, J. H., and Correa, P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol., 20: 1161-1181, 1996.
17. Guarner, J., Herrera-Goepfert, R., Mohar, A., Sanchez, L., Halperin, D. Ley, C., et al. Interobserver variability in application of the revised Sydney classification for gastritis. Hum. Pathol., 30: 1431-1434, 1999.
18. van Grieken, N. C., Weiss, M. M., Meijer, G. A., Bloemena, E., Lindeman, J., Offerhaus, G. J., et al. Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J. Clin. Pathol., 54: 63-69, 2001.
19. Di Napoli, A., Petrino, R., Boero, M., Bellis, D., and Chiandussi, L. Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori. J. Clin. Pathol., 45: 796-798, 1992.
20. You, W. C., Zhang, L., Yang, C. S., Chang, Y. S., Issaq, H., Fox, S. D., et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int. J. Cancer, 83: 615-619, 1999.
21. Plummer, M., Buiatti, E., Lopez, G., Peraza, S., Vivas, J., Oliver, W., et al. Histological diagnosis of precancerous lesions of the stomach: a reliability study, Int. J. Epidemiol., 26: 716-720, 1997.
22. Chen, X., van der Hulst, R. W. M., Bruno, M. J., van der Ende, A., Xiao, S., Tytgat, G. N. J., et al. Interobserver variation in the histopathological scoring of Helicobacter-related gastritis. J. Clin. Pathol., 52: 612-615, 1999.
23. Tepes, B., Ferlan-Marolt, V., Jutersek, A., Kavcic, B., and Zaletel-Krageli, L. Interobserver agreement in the assessment of gastritis reversibility after Helicobacter pylori eradication. Histopathology, 34: 124-133, 2001.
24. You, W., Blot, W. J., Li, J. Y., Chang, Y., Jin, M., Kneller, R. W., et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res., 53: 1317-1321, 1993.
25. Fendrick, A. M., Chemew, M. E., Hirth, R. A., Bloom, B. S., Bandekar, R. R., and Scheiman, J. M. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch. Intern. Med., 159: 142-148, 1999.
26. Malfertheiner, P., Megraud, F., O'Morain, C., Bell, D., Bianchi, P. G., Deltenre, M., et al. Current European concepts in the management of Helicobacter pylori infection-the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur. J. Gastroenterol. Hepatol., 9: 1-2, 1997.
27. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA, 272: 65-69, 1994.
28. Moss, S. F. The carcinogenic effect of H. pylori on the gastric epithelial cell. J. Physiol. Pharmacol., 50: 847-856, 1999.
29. Rugge, M., Farinati, F., Baffa, R., Sonego, F., Di Mario, F., Leandro, G., et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Gastroenterology, 107: 1288-1296, 1994.
30. Rokkas, T., Filipe, M. I., and Sladen, G. E. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut, 32: 1110-1113, 1991.
31. Wu, M. S., Shun, C. T., Lee, W. C., Chen, C. J., Wang, H. P., Lee, W. J., et al. Gastric cancer risk in relation to Helicobacterpylori infection and subtypes of intestinal metaplasia. Br. J. Cancer, 78: 125-128, 1998.
32. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., et al. Helicobacterpylori infection and the development of gastric cancer. N. Engl. J. Med., 345: 784-789, 2001.